Jane Street Group LLC bought a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 8,369 shares of the medical instruments supplier’s stock, valued at approximately $242,000.

Other hedge funds have also made changes to their positions in the company. Mason Street Advisors LLC increased its stake in shares of Merit Medical Systems by 17.9% in the first quarter. Mason Street Advisors LLC now owns 11,491 shares of the medical instruments supplier’s stock worth $332,000 after buying an additional 1,748 shares in the last quarter. Norges Bank acquired a new stake in Merit Medical Systems during the fourth quarter worth $7,773,000. MARSHALL WACE ASIA Ltd acquired a new stake in Merit Medical Systems during the first quarter worth $15,657,000. Russell Investments Group Ltd. acquired a new stake in Merit Medical Systems during the fourth quarter worth $503,000. Finally, Swiss National Bank boosted its stake in Merit Medical Systems by 10.1% in the first quarter. Swiss National Bank now owns 81,700 shares of the medical instruments supplier’s stock worth $2,361,000 after buying an additional 7,500 shares in the last quarter. Hedge funds and other institutional investors own 92.13% of the company’s stock.

Merit Medical Systems, Inc. (NASDAQ:MMSI) traded down 0.48% during midday trading on Thursday, reaching $41.30. The company’s stock had a trading volume of 373,027 shares. Merit Medical Systems, Inc. has a 12 month low of $20.70 and a 12 month high of $42.25. The stock has a 50-day moving average price of $37.83 and a 200 day moving average price of $32.25. The company has a market cap of $2.06 billion, a PE ratio of 59.86 and a beta of 1.25.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.29 by $0.07. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The firm had revenue of $186.50 million for the quarter, compared to analyst estimates of $181.46 million. During the same period in the prior year, the firm earned $0.26 earnings per share. The business’s quarterly revenue was up 23.4% compared to the same quarter last year. Analysts expect that Merit Medical Systems, Inc. will post $1.24 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Jane Street Group LLC Purchases New Position in Merit Medical Systems, Inc. (MMSI)” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/03/jane-street-group-llc-buys-shares-of-8369-merit-medical-systems-inc-mmsi-updated-updated-updated.html.

Several research firms have recently commented on MMSI. Bank of America Corporation assumed coverage on Merit Medical Systems in a research note on Thursday, July 20th. They issued a “buy” rating and a $44.00 target price for the company. Sidoti reiterated a “buy” rating and set a $46.00 target price (up from $41.00) on shares of Merit Medical Systems in a report on Wednesday, June 28th. Wells Fargo & Company began coverage on Merit Medical Systems in a report on Wednesday, April 5th. They issued an “outperform” rating and a $31.70 price target on the stock. BidaskClub upgraded Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 27th. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $37.00 target price on shares of Merit Medical Systems in a research report on Friday, April 28th. One investment analyst has rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $39.74.

In other Merit Medical Systems news, insider Richard W. Edelman sold 20,000 shares of the stock in a transaction that occurred on Friday, June 30th. The shares were sold at an average price of $37.62, for a total value of $752,400.00. Following the transaction, the insider now directly owns 35,000 shares in the company, valued at $1,316,700. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Richard W. Edelman sold 29,000 shares of the stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $41.19, for a total transaction of $1,194,510.00. Following the completion of the transaction, the insider now owns 35,000 shares in the company, valued at $1,441,650. The disclosure for this sale can be found here. Insiders have sold 111,944 shares of company stock worth $4,138,637 over the last 90 days. Insiders own 5.60% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.